AFATINIB- Osimertinib sequential therapy allows patients to stay longer on chemotherapy-free treatment
Document ID: PC-VN-101462
28/06/2021
Author: Boehringer Ingelheim
123,000
Views
100k 340
NHỮNG NỘI DUNG LIÊN QUAN
PC-VN-101462
Production date: June 2021
Production date: June 2021